Pirfenidone for the Treatment of Patients With Pulmonary Fibrosis/Idiopathic Pulmonary Fibrosis (PF/IPF) - Related Studies

Pirfenidone for the Treatment of Patients With Pulmonary Fibrosis/Idiopathic Pulmonary Fibrosis (PF/IPF)

This study is ongoing, but not recruiting participants.

Study NCT00080223. Last updated on March 19, 2008. Information provided by InterMune

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Idiopathic Pulmonary Fibrosis
		Pulmonary Fibrosis

2	Additional conditions recognized in this trial
		Fibrosis

3	More general conditions related to this trial
		Lung Diseases
		Lung Diseases, Interstitial
		Pathologic Processes
		Respiratory Tract Diseases

4	Interventions listed in this trial
		Pirfenidone

5	More general drug interventions related to this trial
		Analgesics
		Analgesics, Non-Narcotic
		Anti-Inflammatory Agents
		Anti-Inflammatory Agents, Non-Steroidal
		Antineoplastic Agents
		Antirheumatic Agents
		Central Nervous System Agents
		Peripheral Nervous System Agents
		Pharmacologic Actions
		Physiological Effects of Drugs
		Sensory System Agents
		Therapeutic Uses

6	Sponsors listed in this trial
		InterMune